Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05073354 · ClinicalTrials.gov registry record
Rapid Treatment of Shock Without Trauma
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 27
- Enrollment target
NCT05073354: Completed study, sponsored by Zoll Medical Corporation.
NCT05073354 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05073354 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Evaluate the implementation of a standardized mobile resuscitation model to manage SWOT within a large acute care hospital setting.
Primary Outcome
Duration in minutes from activation of the SWOT Team to shock reversal, defined as stable arterial pressure (SBP \> 90 mmHg) without requirement for vasopressor administration for greater than 24 hours and normalization of systemic and local perfusion measures of lab-measured lactate indicating improved systemic perfusion
Interventions
- DEVICE Full SWOT Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2024-04-05 |
What the finished NCT05073354 record still lists
NCT05073354 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Full SWOT Model is the first listed.
NCT05073354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05073354 about?
NCT05073354 is a clinical study titled "Rapid Treatment of Shock Without Trauma". Evaluate the implementation of a standardized mobile resuscitation model to manage SWOT within a large acute care hospital setting.
What is the current status of trial NCT05073354?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-06-29. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT05073354?
The interventions under investigation include: Full SWOT Model (DEVICE).
Who is sponsoring clinical trial NCT05073354?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI